Don’t Miss Out! Special Year End Subscription Available

Learn More

Global Opportunities in Neurostimulation Technologies Markets Targeting Chronic Pain

64 Pages | 21 Exhibits | Forecasts Through 2024
market-report-samples/GlobalMarketSegments2.jpg market-report-samples/GlobalMarketSegments3caps.jpg market-report-samples/GlobalMarketSegmentsCaps.jpg
Buy Now

Overview

The global market for neurostimulation devices targeting chronic pain was estimated at $2.52 billion in 2018, comprised almost exclusively of spinal cord stimulation (SCS) systems.  Peripheral nerve stimulation (PNS) represent a much newer development that has only emerged as a meaningful segment with the introduction of next-generation products featuring miniature neurostimulators that communicate with external power sources via wireless technology.  Global sales of these next generation PNS systems were estimated at only $13.3 million in 2018 but are expected to see 34.7% real annual sales growth through 2024 to nearly $80 million as device sales increase from 2,000 in 2018 to 11,675 in 2024.  A detailed analysis of the global neurostimulation devices market and the competitive landscape is included in this new report.

Table of Contents

Executive Summary

Prevalence of High Impact Chronic Pain

Neurostimulation Technologies Targeting High Impact Chronic Pain

Product Markets

Supplier Shares

 

Summary Exhibit 1: Trend in Adults Experiencing High Impact Chronic Pain, by Major Geography, 2018-2024

Summary Exhibit 2: Major Neurostimulation Approaches to Chronic Pain

Summary Exhibit 3: Global Spinal Cord and Peripheral Nerve Stimulation, Implantations and Product Sales, 2018-2024

Summary Exhibit 4: Global Market for Neurostimulation Technologies Targeting High Impact Chronic Pain, by Major Geography, 2018-2024

Summary Exhibit 5: Neurostimulation Systems Targeting High Impact Chronic Pain, Supplier Share, 2018

 

1. Epidemiology of Chronic Pain

1.1 Neurobiology of Pain

1.2 Chronic Pain

1.2.1High Impact Chronic Pain

1.2.2 Prevalence

 

Exhibit 1-1: Estimated Global Adults with Chronic Pain and High-Impact Chronic Pain, 2018

Exhibit 1-2: Trend in Adults Experiencing High Impact Chronic Pain, by Major Geography, 2018-2024

 

2. Products and Technologies

2.1 Spinal Cord Stimulation Systems

2.1.1Nalu Medical

2.1.2Nevro

2.1.3Stimwave

2.1.4Saluda Medical

2.2 Peripheral Nerve Stimulation Systems

2.2.1Bioness

2.2.2 BlueWind Medical

2.2.3 Mainstay Medical

2.2.4 Neuros Medical

2.2.5 SPR Therapeutics

2.2.6 Stimwave

 

Exhibit 2-1: Comparison of Major Neurostimulation Approaches to Chronic Pain

Exhibit 2-2: Selected Spinal Cord Stimulation Systems, 2019

Exhibit 2-3: Selected Peripheral Nerve Stimulation, 2019

 

3. Markets

3.1 Global Supplier Shares

3.2 Market by Major Geography

3.2.1 United States

3.2.2 Major Europe

3.2.3 Major Asia-Pacific

 

Exhibit 3-1: Global Spinal Cord and Peripheral Nerve Stimulation, Implantations and Product Sales, 2018-2024

Exhibit 3-2: Neurostimulation Systems Targeting Chronic Pain, Supplier Shares, 2019

Exhibit 3-3: Global Market for Neurostimulation Technologies Target Chronic Pain, by Major Geography, 2018-2024

Exhibit 3-4: U.S. Market for Neurostimulation Technologies Targeting Chronic Pain, 2018-2024

Exhibit 3-5: Neurostimulation Systems Targeting Chronic Pain, U.S. Supplier Shares, 2018

Exhibit 3-6: Major Europe Market for Neurostimulation Technologies Targeting Chronic Pain, 2018-2024

Exhibit 3-7: Neurostimulation Systems Targeting Chronic Pain, Major Europe Supplier Shares, 2018

Exhibit 3-8: Major Asia-Pacific Market for Neurostimulation Technologies Targeting Chronic Pain, 2018-2024

Exhibit 3-9: Neurostimulation Systems Targeting Chronic Pain, Major Asia-Pacific Supplier Shares, 2018

Exhibit 3-10: Rest-of-World Market for Neurostimulation Technologies Targeting Chronic Pain, 2018-2024

Exhibit 3-11: Neurostimulation Systems Targeting Chronic Pain, Rest-of-World Supplier Shares, 2018

Companies Covered

Abbott/St. Jude Medical

Bioness

BlueWind

Boston Scientific

Medtronic

Mainstay

Nalu Medical

Nevro

Nuvectra

Saluda Medical

SPR Therapeutics

Stimwave

Other Emerging Players